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486Objective: To evaluate the clinical outcomes after aortic valve replacement or aortic valve replacement and cor-
onary artery bypass grafting in a large contemporary population, and to determine if outcomes are associated
with patient ethnicity and gender status.
Methods: Using the Massachusetts Cardiac Surgery Database, we identified 6809 adults aged 18 years or older
who had undergone isolated aortic valve replacement or aortic valve replacement and coronary artery bypass
grafting in all non-federal acute-care Massachusetts hospitals from 2002 to 2008. Univariate and multivariate
logistic regression analyses were used to identify differences in patient characteristics, major morbidity, and
30-day and 1-year mortality between men (n ¼ 4043) and women (n ¼ 2766) and between whites
(n ¼ 6481) and nonwhites (n ¼ 328).
Results: The unadjusted 30-day mortality rate was 2.6% for the men and 3.1% for the women (P ¼ .296) and
2.8% for whites and 3.7% for nonwhites (P¼ .342). In adjusted logistic regression models, the 30-day mortality
was not different between the female and male patients (odds ratio, 0.88; 95% confidence interval, 0.26–3.02,
P¼ .84) nor between the nonwhites and whites (odds ratio, 1.57; 95% confidence interval, 0.45–5.44; P¼ .48).
The incidence of postoperative stroke was greater in women (3.0% women and 2.2% men, P ¼ .031), and the
incidence of postoperative myocardial infarction (10.9% women and 13.6% men; P ¼ .001) and septicemia
(1.2% women and 2.0% men; P ¼ .009) was greater in men.
Conclusions: Ethnicity and gender were not associated with greater 30-day and 1-year mortality after aortic
valve replacement or aortic valve replacement and coronary artery bypass grafting. Differences in postoperative
outcomes were not observed between ethnic groups. (J Thorac Cardiovasc Surg 2012;144:486-92)During the past few years, a growing number of studies have
focused on the differences in outcome between men and
women undergoing coronary artery bypass grafting
(CABG) or aortic valve replacement (AVR).1-4 Other
studies have investigated the relationship between race
and outcomes after AVR.5 Although many of those studies
have examined gender and race differences in patients un-
dergoing CABG,6,7 few have studied patients undergoing
AVR.5,8 Previous studies have shown that black race and
female gender are independent predictors of mortality
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The Journal of Thoracic and Cardiovascular Surgavailable on the predictors of outcome after CABG, we
were not able to identify any study that explicitly
investigated the influence of both race and gender on the
outcomes of AVR or AVR and CABG.
The Massachusetts Cardiac Surgery Database provides
a unique opportunity to address this important question us-
ing a contemporary state-mandated registry. Our study
sought to answer the following questions. First, whether
nonwhites have poorer outcomes after AVR or AVR and
CABG compared with whites; and, second, whether women
have worse outcomes after AVR or AVR and CABG com-
pared with men.
METHODS
Patients
The Massachusetts Cardiac Surgery Database was queried and identi-
fied 6809 patients aged 18 years or older with aortic stenosis who under-
went AVR or CABG and AVR from January 2002 to December 2008 in
all non-federal acute care hospitals in Massachusetts. The baseline demo-
graphics, procedural data, and perioperative outcomes were recorded and
entered prospectively in a prespecified database by dedicated hospital
data managers. We identified 6879 patients with aortic stenosis undergoing
isolated AVR or isolated AVR and CABG surgery from January 1, 2002 to
September 30, 2008. We excluded 58 patients we could not assign to a me-
chanical or bioprosthetic prosthesis type and another 12 patients with miss-
ing race information. Of the remaining 6809 patients, 3 were removed from
the multivariate analyses because of missing data for 1 or more model
covariates.ery c August 2012
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
OR ¼ odds ratio
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MLong-term survival data were obtained from 3 different sources: hospi-
tal, Massachusetts Registry of Vital Statistics, and Social Security death in-
dex website (http://ssdi.rootsweb.ancestry.com/). Because Massachusetts
hospitals are not required to report the long-term outcomes, we restricted
the analysis of 1-year mortality to Massachusetts residents to ensure
follow-up completeness.
Study Design and Conduct
This was a retrospective cohort study of prospectively collected data
from consecutive patients who underwent AVR or AVR and CABG inMas-
sachusetts. The institutional review board approved the study. Patient con-
fidentiality was maintained at all times, consistent with the Health
Insurance Portability and Accountability Act of 1996 regulations.
Definitions
The Society of Thoracic Surgeons’ national cardiac surgery database
definitions were used for this study. A history of strokewas defined as a his-
tory of central neurologic deficit persisting for more than 24 hours. Chronic
renal insufficiency was defined as a serum creatinine value of 2.0 mg/dL or
more. Diabetes was defined as a history of diabetes mellitus, regardless of
the disease duration, or the need for oral diabetes agents or insulin. Postop-
erative stroke was defined as any new major (type I) neurologic deficit pre-
senting in-hospital and persisting for longer than 72 hours. Acute renal
failure was defined as 1 or both of the following: (1) an increase in the se-
rum creatinine to more than 2.0 mg/dL and/or a greater than twofold in-
crease in the most recent preoperative creatinine level; or (2) a new
requirement for dialysis postoperatively.
Statistical Analysis
Univariate analysis. Univariate comparisons of the preoperative,
operative, and postoperative variables were performed between men and
women and between white and nonwhite patients. Continuous variables
were summarized using the mean, median, and range, and frequencies
and percentages are reported for categorical variables. Continuous vari-
ables were tested using the t test, and categorical variables were assessed
using the chi-square test or Fisher’s exact test, depending on the distribu-
tion of the data. P<.05 was considered statistically significant.
Multivariate analysis. We first estimated the differences in out-
comes between genders and between ethnic groups without adjusting for
clinical need. We then adjusted for clinical need using variables to charac-
terize patient acuity and comorbidity (see Appendix 1). We defined clinical
need as hypertension, acute myocardial infarction, hemodialysis, a history
of stroke, diabetes, chronic lung disease, congestive heart failure, age (mea-
sured as number of years older than age 65 years), and bodymass index.We
computed odds ratios and the corresponding 95% confidence intervals
through an estimation of the logistic regression models.
Survival Analysis
Unadjusted survival estimates were calculated using Kaplan-Meier
curves and were compared between men and women and then between
white and nonwhite patients using the log-rank test. Cox proportional haz-
ards models were computed to adjust the interval to death for patients withThe Journal of Thoracic and Cadiffering survival follow-up times (Appendix 2). The subjects who were
alive at the end of our follow-up period were censored. The patients who
underwent subsequent AVR were also censored . All analyses were con-
ducted using SAS, version 9.2 (SAS Institute, Cary, NC).RESULTS
Univariate Analysis
Men versus women. The patient characteristics stratified
by gender and race are listed in Table 1. Men were more
likely to be younger (P<.0001), have a lower body mass in-
dex (P¼ .001), have diabetes (P¼ .010), have experienced
acute myocardial infarction (P<.0001), require hemodial-
ysis (P ¼ .037), have undergone percutaneous coronary in-
tervention before surgery (P< .001) and previous CABG
(P<.001), have a lower ejection fraction (P<.0001), and
have postoperative septicemia (P ¼ .009) than were the
women. The women were more likely to have congestive
heart failure (P<.0001), hypertension (P ¼ .006), under-
gone previous valve surgery (P ¼ .001) and experienced
postoperative stroke (P ¼ .031) than were the men.
White versus nonwhite. The nonwhite patients were
younger (P < .0001) and more likely to have diabetes
(P<.0001) and congestive heart failure (P ¼ .029), more
likely to require hemodialysis (P<.0001), and to have un-
dergone previous valve surgery (P ¼ .001). They were less
likely to have undergone previous CABG (P ¼ .008), to
have a mechanical prosthesis (P<.0001), to have a lower
cardiopulmonary bypass time (P ¼ .029), to have a lower
crossclamp time (P ¼ .031), and to receive a smaller pros-
thesis type (P<.0001) than were the white patients.
The postoperative outcomes stratified by both gender and
race are presented in Table 2. Nonwhite male patients were
younger (P<.0001) and were more likely to have diabetes
(P<.0001), require hemodialysis (P ¼ .001), and have un-
dergone previous valve surgery (P ¼ .02). They were less
likely to have undergone previous CABG (P¼ .036), to un-
dergo surgery on urgent or emergent basis (P<.0001), to
receive a smaller prosthesis type (P<.0001), and to have
postoperative acute myocardial infarction (P ¼ .004) than
were white male patients (Table 2) . Nonwhite female pa-
tients were younger (P< .0001) and were more likely to
have diabetes (P ¼ .043), have undergone previous valve
surgery (P ¼ .025), require hemodialysis (P < .0001),
have a lower crossclamp time (P ¼ .035), and receive
a smaller prosthesis type (P ¼ .003) and more likely to re-
ceive a mechanical valve (P<.0001) compared with white
female patients (Table 2).Survival Analysis
Unadjusted Kaplan-Meier survival curves are presented
in Figures 1 and 2. A total of 27 patients underwent
additional AVR surgery and were censored. Survival was
no different between the male and female patients
(P ¼ .796). Similarly, no difference in survival rates wasrdiovascular Surgery c Volume 144, Number 2 487
TABLE 1. Preoperative, intraoperative, and postoperative characteristics by gender and race
Characteristic
Hospital admissions
Men (n ¼ 4043) Women (n ¼ 2766) P value White (n ¼ 6481) Nonwhite (n ¼ 328) P value
Age (y) 71.0  11.0 73.9  10.3 <.0001 72.5  10.7 66.8  12.4 <.0001
BMI (kg/m2) 28.5  6.7 29.0  7.2 .001 28.7  6.9 28.6  5.9 .738
BSA 2.0  0.2 1.8  0.2 <.0001 1.9  0.2 1.8  0.2 <.0001
EF (%) 53.3  13.9 58.0  11.8 <.0001 55.2  13.3 55.2  13.8 .970
Hypertension 3058 (75.6) 2170 (78.5) .006 4976 (76.8) 252 (76.8) .987
AMI 916 (22.7) 439 (15.9) <.0001 1286 (19.8) 69 (21.0) .597
Hemodialysis 83 (2.1) 38 (1.4) .037 102 (1.6) 19 (5.8) <.0001
History of stroke 279 (6.9) 194 (7.0) .856 445 (6.9) 28 (8.5) .246
Diabetes 1246 (30.8) 772 (27.9) .010 1884 (29.1) 134 (40.9) <.0001
Infectious endocarditis 48 (1.2) 20 (0.7) .059 62 (1.0) 6 (1.8) .121
Previous valve surgery 84 (2.1) 94 (3.4) .001 160 (2.5) 18 (5.5) .001
Previous CABG 447 (11.1) 138 (5.0) <.0001 570 (8.8) 15 (4.6) .008
Previous PCI 586 (14.5) 236 (8.5) <.0001 788 (12.2) 34 (10.4) .331
Chronic lung disease .129 .354
None 3343 (82.7) 2277 (82.4) 5339 (82.4) 281 (85.7)
Mild 385 (9.5) 301 (10.9) 659 (10.2) 27 (8.2)
Moderate 205 (5.1) 126 (4.6) 320 (4.9) 11 (3.4)
Severe 110 (2.7) 61 (2.2) 162 (2.5) 9 (2.7)
CHF 1401 (34.7) 1119 (40.5) <.0001 2380 (36.7) 140 (42.7) .029
Case priority .082 <.0001
Elective 2646 (65.4) 1773 (64.1) 4243 (65.5) 176 (53.7)
Urgent 1356 (33.5) 976 (35.3) DS* DS*
Emergent 41 (1.0) 17 (0.6) DS* DS*
Intraoperative
Prosthesis type .092 <.0001
Mechanical 477 (11.8) 290 (10.5) 708 (10.9) 59 (18.0)
Bioprosthesis 3566 (88.2) 2476 (89.5) 5776 (89.1) 269 (82.0)
Mean gradient across aortic valve 45.9 (18.0) 50.1 (19.0) <.0001 47.7 (18.5) 46.8 (18.5) .419
CPB time (min) 140.8 (52.2) 124.7 (47.2) <.0001 134.6 (50.9) 128.3 (49.1) .029
Crossclamp time (min) 105. 8 (40.3) 93.1 (36.5) <.0001 100.9 (39.3) 96.1 (38.3) .031
Aortic implant size 23.3 (1.9) 20.8 (1.5) <.0001 22.3 (2.2) 21.5 (2.0) <.0001
Median 23.0 21.0 23.0 21.0
Range 17.0 11.0 19.0 10.0
Postoperative
AMI 548 (13.6) 302 (10.9) .001 818 (12.6) 32 (19.8) .126
Stroke 89 (2.2) 84 (3.0) .031 162 (2.5) 11 (3.4) .338
ARF 191 (4.7) 105 (3.8) .065 278 (4.3) 18 (5.5) .299
Septicemia 82 (2.0) 33 (1.2) .009 DS* DS* .265
Hemodialysis 64 (1.6) 49 (1.8) .552 DS* DS* .844
Pericardial tamponade 21 (0.5) 13 (0.5) .776 DS* DS* .771
Reoperation for bleeding 140 (3.5) 76 (2.7) .098 208 (3.2) 8 (2.4) .437
Any reoperation 261 (6.5) 161 (5.8) .286 404 (6.2) 18 (5.5) .585
Mortality
30 d 107 (2.6) 85 (3.1) .296 180 (2.8) 12 (3.7) .342
1 yy 292 (8.2) 201 (8.0) .796 471 (8.2) 22 (7.1) .526
Data presented as mean  standard deviation or numbers, with percentages in parentheses. BMI, Body mass index; BSA, body surface area; EF, ejection fraction; AMI, acute
myocardial infarction; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; CHF, congestive heart failure; CPB, cardiopulmonary bypass; ARF,
acute renal failure; DS, data suppressed. *Cells suppressed according to Massachusetts Department of Public Health reporting guidelines. If a cell contained a frequency<6
(or enabled determination of a cell frequency<6), cells were suppressed. yExcluded non-Massachusetts residents (473 male and 252 female nonresidents and 705 white and
20 nonwhite nonresidents).
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Mobserved between whites and nonwhites (P ¼ .526). No
difference was seen in survival between the AVR and
AVR plus CABG patients in the different gender and
ethnic groups (data not shown).488 The Journal of Thoracic and Cardiovascular SurgMultivariate Analysis
On multivariate logistic regression analysis, no differences
wereobserved inmortality between thewomenandmen (odds
ratio [OR], 0.88; 95% confidence interval [CI], 0.26–3.02;ery c August 2012
TABLE 2. Preoperative, intraoperative, and postoperative characteristics by gender and race
Variable White men Nonwhite men P value White women Nonwhite women P value
Admissions 3866 177 2615 151
Preoperative
Age (y) 71.3  10.9 65.8  12.2 <.0001 74.3  10.0 68.2  12.5 <.0001
BMI (kg/m2) 28.5  6.7 28.4  5.6 .805 29.1  7.3 28.8  6.2 .735
BSA 2.0  0.2 1.9  0.2 <.0001 1.8  0.2 1.7  0.2 .061
EF (%) 53.3  13.8 53.3  14.9 .843 58.0  11.9 57.9  11.7 .905
Hypertension 2925 (75.7) 133 (75.1) .875 2051 (78.5) 119 (78.8) .920
AMI 877 (22.7) 39 (22.0) .840 409 (15.6) 30 (19.9) .167
Hemodialysis 73 (1.9) 10 (5.6) .001 29 (1.1) 9 (6.0) <.0001
History of stroke 263 (6.8) 16 (9.0) .251 182 (7.0) 12 (7.9) .645
Diabetes 1165 (30.1) 81 (45.8) <.0001 719 (27.5) 53 (35.1) .043
Infectious endocarditis DS* DS* .040 DS* DS* .927
Previous valve surgery 76 (2.0) 8 (4.5) .020 84 (3.2) 10 (6.6) .025
Previous CABG 436 (11.3) 11 (6.2) .036 DS* DS* .174
Previous PCI 564 (14.6) 22 (12.4) .425 224 (8.6) 12 (7.9) .791
Chronic lung disease .473 .639
None 3192 (82.6) 151 (85.3) 2147 (82.1) 130 (86.1)
Mild 370 (9.6) 15 (8.5) 289 (11.1) 12 (7.9)
Moderate DS* DS* DS* DS*
Severe DS* DS* DS* DS*
CHF 1330 (34.4) 71 (40.1) .119 1050 (40.2) 69 (45.7) .177
Case priority <.0001 .116
Elective 2557 (66.1) 89 (50.3) 1686 (64.5) 87 (57.6)
Urgent DS* DS* 912 (34.9) 64 (42.4)
Emergent DS* DS* 17 (0.7) 0 (0.0)
Intraoperative
Mean gradient across aortic valve 45.9 (17.9) 45.8 (19.5) .902 50.2 (19.1) 48.0 (17.4) .169
Perfusion time (min) 141.0 (52.4) 135.4 (49.0) .162 125.0 (47.2) 119.9 (48.2) .195
Crossclamp time (min) 105.9 (40.3) 103.8 (40.5) .509 93.5 (36.6) 87.0 (33.3) .035
Aortic implant size 23.4 (1.9) 22.5 (1.8) <.0001 20.8 (1.5) 20.4 (1.5) .003
Median 23.0 23.0 21.0 21.0
Range 17.0 10.0 11.0 8.0
Prosthesis type .053 .0001
Mechanical 448 (11.6) 29 (16.4) 260 (9.9) 30 (19.9)
Bioprosthesis 3418 (88.4) 148 (83.6) 2355 (90.1) 121 (80.1)
Postoperative
AMI 537 (13.9) 11 (6.2) .004 281 (10.7) 21 (13.9) .226
Stroke, permanent 83 (2.1) 6 (3.4) .270 DS* DS* .840
Renal failure 183 (4.7) 8 (4.5) .896 95 (3.6) 10 (6.6) .062
Reoperation for bleeding DS* DS* .083 70 (2.7) 6 (4.0) .343
Any reoperation 254 (6.6) 7 (4.0) .166 150 (5.7) 11 (7.3) .429
Mortality
30 d 100 (2.6) 7 (4.0) .261 DS* DS* .862
1 yy 280 (8.2) 12 (7.3) .664 191 (8.1) 10 (7.0) .649
Data presented as mean  standard deviation or numbers, with percentages in parentheses. BMI, Body mass index; BSA, body surface area; EF, ejection fraction; AMI, acute
myocardial infarction; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; CHF, congestive heart failure; CPB, cardiopulmonary bypass; ARF,
acute renal failure; DS, data suppressed. *Cells suppressed according to Massachusetts Department of Public Health reporting guidelines. If a cell contained a frequency<6
(or enabled determination of a cell frequency<6), cells were suppressed. yExcluded non-Massachusetts residents (473 male and 252 female nonresidents and 705 white and
20 nonwhite nonresidents).
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MP¼ .84).We did not observe differences inmortality between
nonwhites and whites (OR, 1.57; 95% CI, 0.45–5.44;
P¼ .48). Also, no significant differencewas seen in mortality
between thenonwhitemenandwhitemen (OR, 1.56; 95%CI,
0.70–3.47; P ¼ .28) or between the nonwhite women and
white women (OR, 1.01; 95% CI, 0.39–2.58; P ¼ .99).The Journal of Thoracic and CaDISCUSSION
A large body of evidence has documented disparities in
surgical outcomes. Most of the disparities research has fo-
cused on the effects of gender or race on the outcomes of
cardiac surgery. For example, the risk of mortality with
CABG remained 29% greater among nonwhites thanrdiovascular Surgery c Volume 144, Number 2 489
FIGURE 1. Kaplan-Meier survival curves by race, with no difference in survival found between whites and nonwhites.
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Mwhites after adjusting for 27 other risk factors.12 Female
gender has also been associated with increased mortality af-
ter CABG, primarily because of the unfavorable preopera-
tive risk profile in women. Women are reported to be
older, have smaller target vessels, and have a greater prev-
alence of comorbidities.11-13 A scarcity of studies has
evaluated the interaction between gender and race on the
outcomes of AVR.
Principal Findings
In our study, no significant difference was found in the
risk-adjusted 1-year mortality between genders or between
racial groups after AVR in Massachusetts. White men were
more likely to experience postoperative acute myocardial
infarction than were nonwhite men. Women were more
likely to experience postoperative stroke than were men,
and men had a greater risk of experiencing postoperative
septicemia than did women. That postoperative stroke490 The Journal of Thoracic and Cardiovascular Surgwas more common in women might have been related to
the greater rate of hypertension and the more advanced
age of the women compared with the men undergoing AVR.
Significant differences were found in the patient charac-
teristics as a function of gender or race. The nonwhite pa-
tients were younger and presented more frequently with
congestive heart failure than did the white patients. The
nonwhite men underwent a significantly greater proportion
of urgent or emergent surgery compared with the white
men. This finding indicates disparate access or use of
appropriate preventive care and diagnostic evaluation for
nonwhite patients, as previously documented.5 Previous
investigators have demonstrated disparate access to cardiac
catheterization, transcatheter interventions, and CABG for
nonwhite patients.14,15
In both racial groups, men were more likely than women
to undergo AVR. Certain comorbidities, such as renal fail-
ure requiring hemodialysis, congestive heart failure, andery c August 2012
FIGURE 2. Kaplan-Meier survival curves by gender, with no difference in survival found between men and women.
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Mdiabetes, were more frequent in the nonwhite population be-
cause of the greater prevalence of these comorbidities in the
nonwhite population.5 That the nonwhite male and female
patients received a greater percentage of mechanical valves
than the white patients was likely related to the younger age
at presentation for the nonwhite patients compared with the
white patients. That more mechanical valves were im-
planted in the nonwhite than in the white patients and
that, on average, mechanical valves have a greater effective
orifice area for the same size of prosthesis compared with
the bioprosthetic valves partially explains the finding that
smaller prostheses were implanted in the nonwhite patients
than in the white patients. Furthermore, nonwhite patients
had a smaller body surface area than did the white patients
(nonwhite body surface area, 1.8  0.2 versus 1.9 0.2 for
whites; P<.0001), necessitating implantation of a smaller
size prosthesis. The smaller body surface area of the non-
white patients might also explain the more expedientThe Journal of Thoracic and Casurgery for nonwhite patients compared with the white pa-
tients, as indicated by the lower cardiopulmonary bypass
and crossclamp time for the nonwhite patients than for the
white patients.
Clinical implications. In our study, gender and race did
not appear to be associated with an increased risk of mortal-
ity after AVR. The risk of stroke was greater for women af-
ter AVR than for men. Racial discrepancies to access to
preventive medicine and referral for expert cardiovascular
care might explain the more urgent or emergent nature of
AVR in the nonwhite population.
Study limitations. The limitations of the present study in-
clude all those inherent to any retrospective, single-state
analysis. The present study was a nonrandomized study in
which unmeasured patient- or procedure-related variables
could have influenced the study results. For our racial com-
parison, we might have been underpowered to detect differ-
ences owing to the relatively small number of nonwhiterdiovascular Surgery c Volume 144, Number 2 491
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Mpatients. All the data for our study were drawn from the
State of Massachusetts database, which is not necessarily
representative of all cardiac surgery practices in the United
States. The sample size was also a limitation in that the
number of nonwhite patients undergoing AVR inMassachu-
setts was small. Another limitation of our study was that the
Society for Thoracic Surgeons’ risk score was not available
during the study period. Furthermore, future studies are re-
quired to evaluate the role of transcutaneous aortic valve re-
placement in the subset of patients who need AVR and have
probably too high a surgical risk to undergo conventional
AVR. Among the strengths of the present study were the
large cohort of patients and the prospective entry of all
data elements into a cardiac surgical database with strict
definitions.References
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S1356-62.APPENDIX 2. Cox proportional hazard analysis of maximum
likelihood estimates
Variable HR 95% CI P value
Gender_race
Nonwhite women 0.791 0.535–1.171 .2412
Nonwhite men 0.849 0.585–1.234 .3920
White women 0.900 0.802–1.010 .0726
Hypertension 0.984 0.858–1.127 .8126
Myocardial infarction 1.414 1.251–1.599 <.0001
Dialysis 4.487 3.514–5.730 <.0001
Stroke 1.496 1.256–1. 781 <.0001
Diabetes 1.450 1.290–1.631 <.0001
Moderate/severe COPD 1.822 1.549–2.144 <.0001
Congestive heart failure 1.671 1.492–1.872 <.0001
Age>65 y 1.047 1.039–1.054 <.0001
Body mass index 0.985 0.974–0.995 .0045
HR, Hazard ratio; CI, confidence interval; COPD, chronic obstructive pulmonary
disease.
ery c August 2012
